Home » Topics » BioWorld Science

BioWorld Science
RSS

Pharmacokinetics and safety of fontolizumab in Crohn's disease

June 1, 2004

Therapeutic benefits of cilansetron in IBS

June 1, 2004

Update on natalizumab in Crohn's disease

June 1, 2004

Medivir continued to make progress during interim period

June 1, 2004

Small molecule broad spectrum anti-herpes simplex virus

May 28, 2004

Novel respiratory syncytial virus inhibitor from Arrow Therapeutics

May 28, 2004

New cathepsin K inhibitors developed at Merck Frosst

May 28, 2004

Nissan Chemical scientists design new TPO receptor agonists

May 28, 2004

Novel retinoid RXR partial agonists claimed as antidiabetic agents by Allergan

May 28, 2004

GSK researchers identify chemokine CCR8 receptor antagonists for use in asthma therapy

May 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...